Too many people in here are too worried about the price when we...

Too many people in here are too worried about the price when we are in an environment where people are scared to even go outside from the fear of catching COVID, let alone sign up to a first-in-human clinical study. I don't believe management could have anticipated that this would happen given how well Australia was going with COVID when the trials started.

If you have conviction in the technology based on fundamental research then you should have no problem holding until Phase 1 trials are over, no matter what the price is doing in the meantime. It doesn't matter if the trials take 6-12 months longer than anticipated, since we are well-funded and there is no new technology that can outpace IBX in what they are trying to do here. The end reward for patient shareholders will be the same.

It's all about the risk to reward, and those who know this will continue holding strong and not worry about daily fluctuations. The price pumped to 22c on announcing HREC approval for clinical trials, what do you think it will do when the trials are complete with a successful result? Multibags from here IMO.